PI
SGNT

PineBridge Investments’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

PineBridge Investments’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,813
Closed -$42K – 1202
2016
Q2 		$42K Hold
2,813
– – ﹤0.01% 985
2016
Q1 		$34K Sell
2,813
-400
-12% -$5.61K ﹤0.01% 1000
2015
Q4 		$51K Buy
3,213
+334
+12% +$5.26K ﹤0.01% 939
2015
Q3 		$44K Buy
2,879
+277
+11% +$5.99K ﹤0.01% 967
2015
Q2 		$63K Sell
2,602
-2,983
-53% -$71.5K ﹤0.01% 894
2015
Q1 		$130K Buy
5,585
+487
+10% +$12.9K ﹤0.01% 855
2014
Q4 		$128K Buy
5,098
+216
+4% +$6.34K ﹤0.01% 855
2014
Q3 		$152K Buy
4,882
+1,588
+48% +$43K 0.01% 739
2014
Q2 		$85K Buy
+3,294
New +$73.2K ﹤0.01% 842

PineBridge Investments's SGNT Position: Q3 2016 in Review

PineBridge Investments sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 2,813 shares — an estimated $42K sold.

PineBridge Investments first reported a position in SGNT in Q2 2014 and held it in 9 quarters. The position peaked at $152K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • PineBridge Investments reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • PineBridge Investments sold 2,813 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $42K.
  • PineBridge Investments first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 9 quarters.
  • PineBridge Investments's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $152K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on PineBridge Investments's 13F filing for Q3 2016, filed 14 Nov 2016.